Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed a consent form agreeing to take part
- People who are female
- People who are 18 years of age or older
- People who have been diagnosed with ovarian cancer
- People who have a tumor sample or abdominal fluid (ascites) available that is planned to be stored in the hospital's research collection (biobank)
Who may not be able to join:
- People whose tumor or fluid sample storage process could interfere with important medical testing needed for their care
- People who are currently pregnant or breastfeeding
- People who have had another type of cancer in the past 5 years, or who currently have another cancer alongside their ovarian cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vincenzo Canzonieri, MD, Centro di Riferimento Oncologico di Aviano (CRO) - IRCCS
Phone: 0434659618
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess if the drugs' sensibility tested in the 3D organoids derived from biopsies could predict the clinical response (PFS) to therapy regimen for each individual ovarian cancer patient.; To assess if the drugs' sensibility tested in the 3D organoids derived from ascites fluids could predict the clinical response (PFS) to therapy regimen for each individual ovarian cancer patient.; To assess if the drugs' sensibility tested in the 3D organoids derived from biopsies could predict the clinical response (PFI) to therapy regimen for each individual ovarian cancer patient.; To assess if the drug...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.